91 related articles for article (PubMed ID: 26567750)
1. Harnessing the alarmin HMGN1 for anticancer therapy.
Yang D; Bustin M; Oppenheim JJ
Immunotherapy; 2015; 7(11):1129-31. PubMed ID: 26567750
[No Abstract] [Full Text] [Related]
2. High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin.
Yang D; Han Z; Alam MM; Oppenheim JJ
Semin Immunol; 2018 Aug; 38():49-53. PubMed ID: 29503123
[TBL] [Abstract][Full Text] [Related]
3. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses.
Yang D; Postnikov YV; Li Y; Tewary P; de la Rosa G; Wei F; Klinman D; Gioannini T; Weiss JP; Furusawa T; Bustin M; Oppenheim JJ
J Exp Med; 2012 Jan; 209(1):157-71. PubMed ID: 22184635
[TBL] [Abstract][Full Text] [Related]
4. The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant.
Wei F; Yang D; Tewary P; Li Y; Li S; Chen X; Howard OM; Bustin M; Oppenheim JJ
Cancer Res; 2014 Nov; 74(21):5989-98. PubMed ID: 25205103
[TBL] [Abstract][Full Text] [Related]
5. Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.
Zuo B; Qi H; Lu Z; Chen L; Sun B; Yang R; Zhang Y; Liu Z; Gao X; You A; Wu L; Jing R; Zhou Q; Yin H
Nat Commun; 2020 Apr; 11(1):1790. PubMed ID: 32286296
[TBL] [Abstract][Full Text] [Related]
6. Release mechanism of high mobility group nucleosome binding domain 1 from lipopolysaccharide-stimulated macrophages.
Murakami T; Hu Z; Tamura H; Nagaoka I
Mol Med Rep; 2016 Apr; 13(4):3115-20. PubMed ID: 26935015
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1α as an intracellular alarmin in cancer biology.
Voronov E; Dinarello CA; Apte RN
Semin Immunol; 2018 Aug; 38():3-14. PubMed ID: 30554608
[No Abstract] [Full Text] [Related]
8. Alarmins and Antitumor Immunity.
Nie Y; Yang D; Oppenheim JJ
Clin Ther; 2016 May; 38(5):1042-53. PubMed ID: 27101817
[TBL] [Abstract][Full Text] [Related]
9. Alarmins and immunity.
Yang D; Han Z; Oppenheim JJ
Immunol Rev; 2017 Nov; 280(1):41-56. PubMed ID: 29027222
[TBL] [Abstract][Full Text] [Related]
10. High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells.
Arts RJW; Huang PK; Yang D; Joosten LAB; van der Meer JWM; Oppenheim JJ; Netea MG; Cheng SC
Front Immunol; 2018; 9():526. PubMed ID: 29593748
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of human high mobility group N1 protein by protein kinase CK2.
Jiang XG; Wang Y
Biochem Biophys Res Commun; 2006 Jul; 345(4):1497-503. PubMed ID: 16729963
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel in vivo phosphorylation sites in high mobility group N1 protein from the MCF-7 human breast cancer cells.
Zou Y; Jiang X; Wang Y
Biochemistry; 2004 May; 43(20):6322-9. PubMed ID: 15147216
[TBL] [Abstract][Full Text] [Related]
13. Harnessing dendritic cells in cancer.
Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
[TBL] [Abstract][Full Text] [Related]
14. Combining Rapid Data Independent Acquisition and CRISPR Gene Deletion for Studying Potential Protein Functions: A Case of HMGN1.
Mehnert M; Li W; Wu C; Salovska B; Liu Y
Proteomics; 2019 Jul; 19(13):e1800438. PubMed ID: 30901150
[TBL] [Abstract][Full Text] [Related]
15. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
16. HMGN1 is dispensable for myogenesis and adipogenesis.
Hill DA; Imbalzano AN
Gene; 2006 Apr; 371(1):59-67. PubMed ID: 16451822
[TBL] [Abstract][Full Text] [Related]
17. [Regulation of antitumor immunity by controlling immune balance].
Wakita D; Nishimura T
Nihon Rinsho; 2005 Apr; 63 Suppl 4():555-61. PubMed ID: 15861710
[No Abstract] [Full Text] [Related]
18. Red alert: labile heme is an alarmin.
Soares MP; Bozza MT
Curr Opin Immunol; 2016 Feb; 38():94-100. PubMed ID: 26741528
[TBL] [Abstract][Full Text] [Related]
19. Alarmins of the extracellular space.
Dziki JL; Hussey G; Badylak SF
Semin Immunol; 2018 Aug; 38():33-39. PubMed ID: 30170910
[TBL] [Abstract][Full Text] [Related]
20. PDL-1/PDL-2 blockade in mice dendritic cells by RNAi techniques to induce antitumor immunity.
Daneshmandi S; Pourfathollah AA; Karimi MH; Emadi-Baygi M
Immunotherapy; 2015; 7(11):1145-58. PubMed ID: 26599163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
